Vireo Growth Third-Quarter GAAP Revenue Jumps 177 Percent to $253.7 Million, With Pro Forma Revenue of $277.0 Million and $106.8 Million Cash
Vireo Growth reported results for its third fiscal quarter ended September 30, 2026, in Minneapolis, Minnesota, on November 10, 2026. GAAP revenue was $253.7 million, up 177 percent year over year, driven, the company said, by recently closed merger and acquisition transactions.
Pro forma revenue was $277.0 million, giving effect to the acquisitions of C21 Investments, certain PharmaCann Colorado assets and the Cannabist Colorado assets as if they were completed on July 1, 2026. GAAP cannabis revenue was $198.1 million and GAAP non-cannabis revenue was $55.6 million.
The company said its annualized revenue run rate exceeded $1 billion based on third-quarter GAAP revenue. It closed the quarter with $106.8 million in cash, launched a share repurchase program and expanded financing capacity with new banking partners.
The results call was scheduled for 8:00 a.m. Eastern Time on November 10. The outlook includes FLUENT from November 9, 2026, and excludes pending acquisitions.
(Source: Vireo Growth)
Source: Vireo Growth
Published by GSM · USA (original Chinese edition)
Photo: 图：室内大麻种植（资料图）。照片：CC BY-SA 4.0，经 Wikimedia Commons。 / Photo: Indoor cannabis cultivation (file photo). CC BY-SA 4.0, via Wikimedia Commons.
